Key result
CCN5-coated stents may overcome current limitations by blocking smooth muscle cell proliferation and promoting re-endothelialization.
Why the study?
Drug-eluting stents overcome bare-metal stent restenosis but cause late-stent thrombosis due to impaired re-endothelialization from broad anti-proliferative effects.
Do CCN5 protein-coated stents overcome the drawbacks of bare-metal and drug-eluting stents by blocking smooth muscle cell proliferation while promoting re-endothelialization?
Do CCN5 protein-coated stents overcome the drawbacks of bare-metal and drug-eluting stents by blocking smooth muscle cell proliferation while promoting re-endothelialization?
CCN5 protein-coated stents are proposed as a novel targeted approach to prevent in-stent restenosis and late-stent thrombosis by differentially affecting vascular cell types.
Answers are grounded in this paper and cite their sources.
CCN5-coated stents warrant preclinical evaluation; hypothesis-generating for clinical efficacy in preventing restenosis and thrombosis.
First-generation, bare-metal stents successfully open and support occluded vessels but are prone to in-stent restenosis caused by excessive vascular smooth muscle cell proliferation. Drug-eluting stents overcome these drawbacks by coating bare-metal stents with anti-proliferative compounds, but due to the broad mechanism of action in blocking proliferation in different cell types, they are associated with late-stent thrombosis caused by delayed or impaired re-endothelialization. CCN5 protein-coated stents are designed to both block smooth muscle cell proliferation and promote re-endothelialization due to the differential functions of CCN5 in these different vascular cell types.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2025) conducted a review in Coronary artery disease. CCN5 protein-coated stents vs. Bare-metal and drug-eluting stents was evaluated. CCN5 protein-coated stents are designed to block smooth muscle cell proliferation and promote re-endothelialization, potentially overcoming the limitations of current stent technologies.
Synapse has enriched 10 related papers. Consider them for comparative context: